Liquid biopsy in pancreatic cancer: the beginning of a new era

@inproceedings{Yadav2018LiquidBI,
  title={Liquid biopsy in pancreatic cancer: the beginning of a new era},
  author={Dipesh Kumar Yadav and Xueli Bai and Rajesh Yadav and Alina Singh and Guogang Li and Tao Ma and Wei Chen and Tingbo Liang},
  booktitle={Oncotarget},
  year={2018}
}
With dismal survival rate pancreatic cancer remains one of the most aggressive and devastating malignancy. Predominantly, due to the absence of a dependable methodology for early identification and limited therapeutic options for advanced disease. However, it takes over 17 years to develop pancreatic cancer from initiation of mutation to metastatic cancer; therefore, if diagnosed early; it may increase overall survival dramatically, thus, providing a window of opportunity for early detection… CONTINUE READING
4
Twitter Mentions

Similar Papers

References

Publications referenced by this paper.
SHOWING 1-10 OF 412 REFERENCES

High prevalence of mutant KRAS in circulating exosome-derived DNA from early-stage pancreatic cancer patients

K Allenson, J Castillo, +10 authors I Holcatova
  • Ann Oncol
  • 2017
VIEW 4 EXCERPTS
HIGHLY INFLUENTIAL

Plasma Circulating Tumor DNA in Pancreatic Cancer Patients Is a Prognostic Marker.

  • Clinical cancer research : an official journal of the American Association for Cancer Research
  • 2017
VIEW 12 EXCERPTS
HIGHLY INFLUENTIAL

Liquid Biopsy Receives Approval

VIEW 3 EXCERPTS
HIGHLY INFLUENTIAL